Last updated on June 2019

A Study to Test the Pharmacokinetics Efficacy and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures


Brief description of study

The purpose of the study is to evaluate the pharmacokinetics (PK) of brivaracetam (BRV) in neonates who have seizures that are not adequately controlled with phenobarbital (PB) treatment and to identify the optimal BRV dose (Exploratory Cohort) for the treatment of subjects enrolled into the Confirmatory Cohorts of this study

Clinical Study Identifier: NCT03325439

Find a site near you

Start Over

N01349 203

Brussels, Belgium
  Connect »

N01349 204

Leuven, Belgium
  Connect »

N01349 205

Praha, Czechia
  Connect »

N01349 218

Erlangen, Germany
  Connect »

N01349 209

Freiburg, Germany
  Connect »

N01349 212

Messina, Italy
  Connect »

N01349 214

Rotterdam, Netherlands
  Connect »

N01349 216

London, United Kingdom
  Connect »

N01349 251

Cambridge, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.